EyeGate (EYEG) Stock Flies On CEO Appointment & Acquisition

EyeGate Pharmaceuticals EYEG Stock News

EyeGate Pharmaceuticals Inc (NASDAQ: EYEG) is screaming for the top in the market this morning, and for good reason. The company announced that not only has it appointed a new CEO, it has entered a non-binding letter surrounding the acquisition of Bayon Therapeutics. Here’s what’s happening: Stop wasting your time! Start finding winning trades in … Read more

EyeGate Pharmaceuticals (EYEG) Stock: Climbing On New Clinical Data

EyeGate Pharmaceuticals Inc (NASDAQ: EYEG) is up in a massive way early in the pre-market this morning after announcing positive top-line clinical data. Of course, the positive data brings the company one step closer to commercialization, exciting investors who are sending the stock screaming for the top. Today, we’ll talk about the data, what we’re … Read more

Eyegate Pharmaceuticals (EYEG) Stock: Soaring On FDA Approval

Eyegate Pharmaceuticals Inc (NASDAQ: EYEG) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced that it has received FDA approval for two indications this morning. Of course, the news excited investors, sending the stock screaming for the top. Today, we’ll talk about: The FDA approvals; … Read more

Eyegate Pharmaceuticals (EYEG) Stock: Rocketing On Patent News

Eyegate Pharmaceuticals Inc (NASDAQ: EYEG) is skyrocketing in the market early on this morning after announcing that it has been issued a patent. The patent is a key factor in protecting the company’s Iontophoretic Contact Lens. Of course, the news of the new intellectual property protection proved to be a source of excitement among investors, … Read more

Eyegate Pharmaceuticals (EYEG) Stock: Flying On Clinical Update

Eyegate Pharmaceuticals Inc (NASDAQ: EYEG) is having an overwhelmingly strong start to the trading session this morning after announcing a clinical update. The update surrounded enrollment in a Phase 3 clinical trial, and the news was positive. Of course, the update led to excitement among investors, sending the stock on a run for the top. … Read more

Eyegate Pharmaceuticals (EYEG) Stock: Skyrockets On Valeant Pharmaceuticals (VRX) Partnership

EyeGate Pharmaceuticals Inc (NASDAQ: EYEG) EyeGate Pharmaceuticals is having an overwhelmingly strong day in the market today. As soon as the market opened for the day, the stock was trading well into the green. Since then, we’ve seen some upward and some downward movement, but the stock has definitely been able to hold onto impressive … Read more